DNA Methylation of : A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer Patients.

Background: Previous studies support a tumor-suppressor role for across various types of cancers. We aimed to investigate the association between DNA methylation of and overall survival (OS) for patients with early-stage non-small cell lung cancer (NSCLC).

Methods: This study included 1,230 patients with early-stage NSCLC.